| Authors: |
Vogel AB; BioNTech RNA Pharmaceuticals GmbH, An der Goldgrube 12, 55131 Mainz, Germany. Electronic address: annette.vogel@biontech.de., Lambert L; Mucosal Infection and Immunity Group, Section of Virology, Department of Medicine, St. Mary's Campus, Imperial College London W2 1PG, UK., Kinnear E; Mucosal Infection and Immunity Group, Section of Virology, Department of Medicine, St. Mary's Campus, Imperial College London W2 1PG, UK., Busse D; Mucosal Infection and Immunity Group, Section of Virology, Department of Medicine, St. Mary's Campus, Imperial College London W2 1PG, UK., Erbar S; BioNTech RNA Pharmaceuticals GmbH, An der Goldgrube 12, 55131 Mainz, Germany., Reuter KC; BioNTech AG, An der Goldgrube 12, 55131 Mainz, Germany., Wicke L; BioNTech RNA Pharmaceuticals GmbH, An der Goldgrube 12, 55131 Mainz, Germany., Perkovic M; TRON GmbH, Freiligrathstraße 12, 55131 Mainz, Germany., Beissert T; TRON GmbH, Freiligrathstraße 12, 55131 Mainz, Germany., Haas H; BioNTech RNA Pharmaceuticals GmbH, An der Goldgrube 12, 55131 Mainz, Germany., Reece ST; BioNTech RNA Pharmaceuticals GmbH, An der Goldgrube 12, 55131 Mainz, Germany., Sahin U; BioNTech AG, An der Goldgrube 12, 55131 Mainz, Germany., Tregoning JS; Mucosal Infection and Immunity Group, Section of Virology, Department of Medicine, St. Mary's Campus, Imperial College London W2 1PG, UK. Electronic address: john.tregoning@imperial.ac.uk. |
